ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,856.79
      -0.08%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cara Therapeutics Inc (CARA)

      7. Cara Therapeutics Inc (CARA) Financials

      Cara Therapeutics Inc

      Cara Therapeutics Inc (CARA)

      NASDAQ
      0.3724
      0.0073
      (2.00%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      0.39
      0.0176
      (4.73%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Cara Therapeutics Inc Financial Summary

      The current CARA market cap is 20.36M. The company's latest EPS is USD -2.1676 and P/E is -0.17.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6.17M6.93M4.87M3M2.14M
      Operating Income -27.65M-32.34M-28.9M-32.61M-29.67M
      Net Income -26.67M-31.48M-28.03M-32.34M-30.7M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 19.89M135.08M23.03M41.87M20.97M
      Operating Income -111.68M5.39M-89.08M-87.54M-121.5M
      Net Income -106.37M8.41M-88.44M-85.47M-118.51M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 153.28M134.39M115.34M125.84M90.1M
      Total Liabilities 16.68M25.46M29.7M68.76M60.3M
      Total Equity 136.6M108.93M85.64M57.09M29.8M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 232.96M271.16M247.06M182.24M125.84M
      Total Liabilities 46.25M22.16M19.53M23.46M68.76M
      Total Equity 186.71M249M227.52M158.78M57.09M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -34.62M-55.06M-74.71M-92.08M-30.45M
      Investing 17.71M50.51M73.67M43.46M25.95M
      Financing 560k560k1.68M38.15M-836k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -109.23M-5.49M-60.09M-78.73M-92.08M
      Investing -30.52M-20.28M-4.75M128.71M43.46M
      Financing 142.6M39.14M46.61M311k38.15M

      Stats and Ratios

      Market Cap 20.36M
      Price to Earnings Ratio -0.17
      Price to Sales Ratio 0.96
      Price to Cash Ratio 0.39
      Price to Book Ratio 0.35
      Dividend Yield -

      Share Statistics

      Shares Outstanding 54.68M
      Average Volume (1 week) 336.12k
      Average Volume (1 Month) 1.06M
      52 Week Change -86.65%
      52 Week High 3.45
      52 Week Low 0.24
      Spread (Intraday) 0.03 (7.18%)

      Company Info

      Company Name Cara Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.caratherapeutics.com
      Industry pharmaceutical preparations (2834)